July 7, 2020 / 1:39 PM / a month ago

BRIEF-Vaccinex Provides Update Of Potentially Pivotal Signal Clinical Trial In Huntington's Disease

July 7 (Reuters) - Vaccinex Inc:

* VACCINEX PROVIDES UPDATE OF POTENTIALLY PIVOTAL SIGNAL CLINICAL TRIAL IN HUNTINGTON’S DISEASE

* VACCINEX INC - REMAINS ON TRACK TO COMPLETE POTENTIALLY PIVOTAL SIGNAL TRIAL IN HD WITHIN ANTICIPATED TIME FRAME

* VACCINEX INC - CONTINUES TO ANTICIPATE THAT DATABASE LOCK WILL BE COMPLETED BY SEPTEMBER

* VACCINEX INC - PRIMARY EFFICACY DATA HAS BEEN COLLECTED FROM ALL SUBJECTS WHO COMPLETED STUDY EXCEPT FOR 2 SUBJECTS

* VACCINEX INC - IDENTIFIED PRIMARY AND SECONDARY ENDPOINTS FOR TWO RANDOMIZED ARMS OF SIGNAL TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below